Showing 321 - 340 results of 1,866 for search '"spondylitis"', query time: 0.10s Refine Results
  1. 321

    Impact of the trace element status on the course of ankylosing spondylitis in the Orenburg Region patients by U. A. Yakubova, O. V. Bugrova, S. I. Krasikov, N. P. Setko, R. I. Saifutdirov

    Published 2019-10-01
    “…The role of trace elements (TEs) and their imbalance in the physiology of bone tissue and in the development of inflammatory diseases of the joints and spine has been discussed in recent years; however, there is no evidence for the TE status of patients with ankylosing spondylitis (AS) and its possible impact on the course of the disease.Objective: to investigate the impact of the TE status of patients with AS on the course, clinical manifestations, and activity of the disease.Patients and methods. …”
    Get full text
    Article
  2. 322
  3. 323

    Antimicrobial resistance of Mycobacterium tuberculosis clinical isolates from patients with tuberculous spondylitis by Lavrenchuk L.S., Minogina T.V., Vakhrusheva D.V., Skornyakov S.N.

    Published 2023-12-01
    “…To conduct a comparative evaluation of the results of phenotypic and molecular genetic methods for testing drug resistance of Mycobacterium tuberculosis isolated from bone biopsies of patients with tuberculous spondylitis. Materials and Methods. A retrospective cohort study was conducted on the case histories of patients diagnosed with tuberculous spondylitis who underwent surgical treatment in the period from 2016 to 2021. …”
    Get full text
    Article
  4. 324
  5. 325

    Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis by Joachim Sieper, Juergen Braun

    Published 2023-07-01
    “…The association of HLA B27 alleles with ankylosing spondylitis (AS), a highly heritable disease, which is part of the spectrum of axial spondyloarthritis (axSpA), was discovered 50 years ago. …”
    Get full text
    Article
  6. 326
  7. 327
  8. 328
  9. 329

    Delayed post-surgical hypoparathyroidism mimicking ankylosing spondylitis: a case report by İlker Şengül, Aliye Tosun, İbrahim Bilir, Aylin Altun, Ayhan Aşkın

    Published 2020-12-01
    “…In this case report, we present the clinical findings of a 55-year-old male patient with delayed post-surgical hypoparathyroidism who had been previously diagnosed ankylosing spondylitis and referred to our clinics for further treatment.…”
    Get full text
    Article
  10. 330
  11. 331
  12. 332

    INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS by Sh. F. Erdes

    Published 2016-09-01
    Subjects: “…ankylosing spondylitis…”
    Get full text
    Article
  13. 333
  14. 334

    An integrated approach to the treatment of ankylosing spondylitis from the position of the international classification of functioning by R. R. Ahunova, G. R. Ahunova

    Published 2020-01-01
    “…Using the IСF in the process of complex therapy and rehabilitation of patients with ankylosing spondylitis, a multidisciplinary team can achieve a more complete coherence of views in the treatment of patients with ankylosing spondylitis, which is very important in achieving the success of therapy of this category of patients.…”
    Get full text
    Article
  15. 335

    Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA by Tao Sun, Manzhi Wang, Weiqiang Liang, Ping Gao, Qiang Liu, Xinfeng Yan

    Published 2023-09-01
    “…Our previous studies have demonstrated the elevation of CA1 expression and the therapeutic effect of Methazolamide in Ankylosing spondylitis (AS). In this study, we explored the pathogenic role of CA1 and the pharmacological mechanism of Methazolamide in AS through Gene Set Enrichment Analysis (GSEA) and network pharmacology. …”
    Get full text
    Article
  16. 336
  17. 337
  18. 338
  19. 339

    Evaluation of the health care budget impact of secukinumab treatment in patients with ankylosing spondylitis by S. K. Zyryanov, I. N. Dyakov, S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk

    Published 2017-04-01
    “…Objective: clinical and economic analysis of including of secukinumab (SEC) in the essential drug list (EDL) and Federal Reimbursement (ONLS) to ensure the availability of the drug to patients with ankylosing spondylitis (AS) at the expense of health. Material and methods. …”
    Get full text
    Article
  20. 340